𝐍𝐞𝐰𝐛𝐨𝐫𝐧 𝐆𝐞𝐧𝐞𝐭𝐢𝐜 𝐓𝐞𝐬𝐭𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐢𝐳𝐞 𝐭𝐨 𝐑𝐞𝐚𝐜𝐡 𝐔𝐒𝐃 𝟒.𝟖 𝐁𝐧 𝐛𝐲 𝟐𝟎𝟑𝟑 According to the Regional Research Reports, the Global Newborn Genetic Testing market is anticipated to reach USD XX billion by 2030 from USD 4.8 billion in 2021. The global Newborn Genetic Testing market is projected to grow at a CAGR of 10.7% from 2022 to 2030. The increasing prevalence of genetic diseases among infants is the major factor positively influencing the growth of the newborn genetic testing market. The risk of genetic diseases in infants is high when parents have another child suffering from a genetic disease or if either of the parents has an abnormality in their chromosomes. Due to the rising number of cases of genetic disorders in infants, governments of many regions are promoting the use of prenatal and newborn genetic testing. Therefore, this factor is further boosting the growth of the market. Request To Download Sample of This Strategic Report: https://www.regionalresearchreports.com/request-sample/global-newborn-genetic-testing-market/HC-1370?utm_source=Free&utm_medium=Harsh+17+april Global Newborn Genetic Testing Market Segmentation Regional Research Reports has segmented the global Newborn Genetic Testing market based on diagnostic, disease, and end user at a regional and global level. Geographically, the research report has considered the five regions: North America, Europe, Asia Pacific, South America, and the Middle East & Africa. Moreover, the research study focuses on the market analysis of the tier-1 countries, such as the USA, China, Germany, India, the UK, Japan, France, Italy, Spain, Russia, South Korea, and other territories. Global Newborn Genetic Testing Market Analysis by Diagnostic Spectrophotometer Polymerase Chain Reaction Fluorescence in-situ Hybridization Array-Comparative Genomic Hybridization Screening Maternal Serum Screening Chronic Villus Sampling Amniocentesis Non-invasive Prenatal Testing Global Newborn Genetic Testing Market Analysis by Disease Cystic Fibrosis Sickle Cell Anemia Down Syndrome Phenylketonuria Others Global Newborn Genetic Testing Market Analysis by End User Hospitals & Clinics Diagnostic Centers Others Global Newborn Genetic Testing Market Growth, by Region and Country, 2018-2021, 2022-2030 (US$ Millions) Global Newborn Genetic Testing Market Analysis by Region and Country North America (US, Canada, Mexico) Europe (Germany, UK, France, Italy, Spain, Russia, Switzerland, Poland, Belgium, the Netherlands, Norway, Sweden, Czech Republic, Slovakia, Slovenia, Rest of Europe) Asia Pacific (China, India, Japan, South Korea, Indonesia, Thailand, Malaysia, Vietnam, Singapore, Australia & New Zealand, Rest of Asia Pacific) South America (Brazil, Argentina, Peru, Colombia, Rest of South America) The Middle East & Africa (UAE, Saudi Arabia, South Africa, Egypt, Qatar, Northern Africa, Rest of MEA) You Can Purchase Complete Report: https://www.regionalresearchreports.com/buy-now/global-newborn-genetic-testing-market/HC-1370?opt=2950&utm_source=Free&utm_medium=Harsh+17+april Global Newborn Genetic Testing Market Competitive: Key Players The report includes a comprehensive analysis of leading market players, such as: Key companies Newborn Genetic Testing revenues in the global market, 2018-2021 (Estimated), (US$ Millions) Key companies Newborn Genetic Testing revenues market share in global market, 2021 (%) Key companies Newborn Genetic Testing sold in the global market, 2018-2021 (Estimated) Leading Newborn Genetic Testing Manufacturers – Ariosa Diagnostics (Roche) Berry Genomics BGI Bio-Rad Laboratories Inc. Illumina Laboratory Corporation of America Natera Qiagen Sequenom Trivitron Healthcare Verinata Health Agilent Technologies Inc. Quest Diagnostics Incorporated F. Hoffmann La-Roche Ltd. PerkinElmer, Inc.